SMTL ID : 4e90.2 (1 other biounit)

Human phosphodiesterase 9 in complex with inhibitors

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.79, H.115, D.116, D.225 Ligands: MG.2 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.79, A:H.115, A:D.116, A:D.225, H2O.3

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: D.116, H.148 Ligands: ZN.1 4 PLIP interactions: 1 interactions with chain A, 3 Ligand-Water interactions Metal complexes: A:D.116, H2O.1, H2O.2, H2O.2

1 x 7RG: 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(Non-covalent)

7RG.3: 10 residues within 4Å: Chain A: H.75, M.188, I.226, L.243, L.244, Y.247, F.264, A.275, Q.276, F.279 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.226, A:L.244, A:Y.247, A:A.275 Hydrogen bonds: A:Q.276, A:Q.276 Water bridges: A:Y.247 pi-Stacking: A:F.264, A:F.279

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Claffey, M.M. et al., Application of structure-based drug design and parallel chemistry to identify selective, brain penetrant, in vivo active phosphodiesterase 9A inhibitors. J.Med.Chem. (2012)

Release Date

2013-02-27

Peptides

High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A

Related Entries With Identical Sequence